Shareholder alert: weisslaw llp investigates chiasma, inc.

New york, may 5, 2021 /prnewswire/ -- weisslaw llp is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of chiasma, inc. ("chiasma" or the "company") (nasdaq: chma) in connection with the proposed acquisition of the company by amryt pharma plc ("amryt") (nasdaq: amyt). under the terms of the merger agreement, chiasma stockholders will receive 0.396 amryt american depositary shares ("adss"), each representing five amryt ordinary shares, for each chiasma share that they own, representing implied consideration of $5.13 based upon amryt's ads's may 4, 2021 closing price of $12.95.
AMYT Ratings Summary
AMYT Quant Ranking